BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21148037)

  • 1. IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection.
    Racine R; McLaughlin M; Jones DD; Wittmer ST; MacNamara KC; Woodland DL; Winslow GM
    J Immunol; 2011 Jan; 186(2):1011-21. PubMed ID: 21148037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-driven induction of polyreactive IgM during intracellular bacterial infection.
    Jones DD; DeIulio GA; Winslow GM
    J Immunol; 2012 Aug; 189(3):1440-7. PubMed ID: 22730531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection.
    Racine R; Chatterjee M; Winslow GM
    J Immunol; 2008 Jul; 181(2):1375-85. PubMed ID: 18606692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired germinal center responses and suppression of local IgG production during intracellular bacterial infection.
    Racine R; Jones DD; Chatterjee M; McLaughlin M; Macnamara KC; Winslow GM
    J Immunol; 2010 May; 184(9):5085-93. PubMed ID: 20351185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The omentum is a site of protective IgM production during intracellular bacterial infection.
    Jones DD; Racine R; Wittmer ST; Harston L; Papillion AM; Dishaw LM; Randall TD; Woodland DL; Winslow GM
    Infect Immun; 2015 May; 83(5):2139-47. PubMed ID: 25776744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells.
    Foote JB; Mahmoud TI; Vale AM; Kearney JF
    J Immunol; 2012 Jan; 188(1):57-67. PubMed ID: 22116821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell activating factor inhibition impairs bacterial immunity by reducing T cell-independent IgM secretion.
    Jones DD; Jones M; DeIulio GA; Racine R; MacNamara KC; Winslow GM
    Infect Immun; 2013 Dec; 81(12):4490-7. PubMed ID: 24082070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.
    Thirumalapura NR; Stevenson HL; Walker DH; Ismail N
    Infect Immun; 2008 May; 76(5):1920-30. PubMed ID: 18285501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens.
    Habib S; El Andaloussi A; Hisham A; Ismail N
    PLoS One; 2016; 11(4):e0153223. PubMed ID: 27092553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis.
    Thirumalapura NR; Crossley EC; Walker DH; Ismail N
    Infect Immun; 2009 Dec; 77(12):5682-9. PubMed ID: 19805532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T-cell epitopes associated with protective immunity induced following vaccination of mice with an ehrlichial variable outer membrane protein.
    Nandi B; Hogle K; Vitko N; Winslow GM
    Infect Immun; 2007 Nov; 75(11):5453-9. PubMed ID: 17698576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection.
    Bitsaktsis C; Nandi B; Racine R; MacNamara KC; Winslow G
    Infect Immun; 2007 Oct; 75(10):4933-41. PubMed ID: 17664264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling.
    MacNamara KC; Oduro K; Martin O; Jones DD; McLaughlin M; Choi K; Borjesson DL; Winslow GM
    J Immunol; 2011 Jan; 186(2):1032-43. PubMed ID: 21149601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-1 cells in the bone marrow are a significant source of natural IgM.
    Choi YS; Dieter JA; Rothaeusler K; Luo Z; Baumgarth N
    Eur J Immunol; 2012 Jan; 42(1):120-9. PubMed ID: 22009734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early derivation of IgM memory cells and bone marrow plasmablasts.
    Papillion AM; Kenderes KJ; Yates JL; Winslow GM
    PLoS One; 2017; 12(6):e0178853. PubMed ID: 28575114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic extrafollicular reactions and BM plasma cells sustain IgM response associated with hypercholesterolemia.
    Khoo LH; Thiam CH; Soh SY; Angeli V
    Eur J Immunol; 2015 May; 45(5):1300-12. PubMed ID: 25639537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow.
    Reynolds AE; Kuraoka M; Kelsoe G
    J Immunol; 2015 Jan; 194(1):231-42. PubMed ID: 25429072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.
    Ghose P; Ali AQ; Fang R; Forbes D; Ballard B; Ismail N
    J Immunol; 2011 Aug; 187(3):1333-46. PubMed ID: 21715688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosis.
    Nandi B; Chatterjee M; Hogle K; McLaughlin M; MacNamara K; Racine R; Winslow GM
    Infect Immun; 2009 Oct; 77(10):4643-53. PubMed ID: 19635826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis.
    Zhang Y; Thai V; McCabe A; Jones M; MacNamara KC
    Infect Immun; 2014 Apr; 82(4):1698-709. PubMed ID: 24491580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.